Skip to main content
. 2005 Jan 31;10(1):126–145. doi: 10.3390/10010126

Figure 9.

Figure 9

Evolution of the adhered fraction of PVM/MA formulations in the whole gastrointestinal tract with the time, after a single oral administration of 10 mg nanoparticles. NP: conventional nanoparticles; D5-NP, D10-NP, D30-NP: cross-linked nanoparticles.